TABLE 2.
Reference | n | Preparation | Efficacy | Tolerability and acceptability |
---|---|---|---|---|
Vanner et al (14) | 102 | NaP
PEG |
NaP > PEG | NaP > PEG |
Kolts et al (15) | 72 | NaP
PEG |
NaP > PEG | NaP = PEG |
Marshall et al (16) | 143 | NaP
PEG |
NaP = PEG | NaP = PEG |
Cohen et al (17) | 422 | NaP
PEG |
NaP > PEG | NaP > PEG |
Golub et al (18) | 230 | NaP
PEG |
NaP = PEG | NaP > PEG |
Henderson et al (19) | 242 | NaP
PEG |
NaP = PEG | NaP > PEG |
Thomson et al (20) | 116 | NaP
PEG |
NaP = PEG | NaP = PEG |
Clarkston et al (21) | 98 | NaP
PEG |
NaP = PEG | NaP = PEG |
Frommer (22) | 486 | NaP
PEG |
NaP > PEG | NaP ≥ PEG |
Lee et al (23) | 209 | NaP
PEG |
NaP = PEG | NaP = PEG |
Arezzo (24) | 300 | NaP
PEG |
NaP > PEG | NaP > PEG |
Kastenberg et al (25) | 845 | NaP tablets
PEG |
NaP tablets = PEG | NaP tablets > PEG |
Law et al (26) | 299 | NaP
PEG |
NaP > PEG | NaP > PEG |
Seinela et al (27) | 72 | NaP
PEG |
NaP = PEG | NaP = PEG |
Hwang et al (28) | 80 | NaP
PEG |
NaP = PEG | NaP = PEG |
Ell et al (29) | 126 | NaP
PEG |
PEG > NaP | PEG ≥ NaP |
Hookey et al (30)* | 171 | NaP + bisacodyl
PEG |
PEG > NaP + bisacodyl | NaP + bisacodyl > PEG |
Young et al (31) | 323 | NaP
PEG + bisacodyl |
NaP > PEG + bisacodyl | NaP > PEG + bisacodyl |
Afridi et al (50) | 147 | NaP + bisacodyl
PEG |
NaP + bisacodyl = PEG | NaP + bisacodyl > PEG |
*Low dose (1×45 mL) of NaP